Velox Details
Fluxus lateralis chromatographicus immunoassay
Secundum principium competitive binding
Anticorpus cum pharmacopola dapibus conjugatis agit
Packaging & Delivery
| Packaging detail: Latin export sarcina Partus detail: in 7-10 fes post recepcionem solucionis |
Specifications
Autoritate Celeri Test Kit AMRDT113
PRINCIPIUM.
Auctoritas Celeri Test Kit AMRDT113 immunoassay est innixa principio obligationis competitive.Medicamenta, quae in specimine urinae adesse possunt, contendunt contra suos medicamentos conjugatos pro ligatura situs in proprio anticorpore.
In probatione urina speciminis sursum migrat per actionem capillarem.Medicamentum, si in specimine urinae sub intentione eius abscise inest, situs ligaturae specificae anticorporis non saturabit.Anticorpus tunc agere faciet cum interdum pharmacopola conjugato et linea visibili colorata ostendet in regione probata lineae speciei medicamentorum habenae.
Praesentia medicamentorum supra intentionem abscissorum omnes situs ligaturae anticorporis saturabit.Ergo linea colorata non formabit in regione recta probata.
Celeri Test Kit AMRDT113 auctoritativus est fluxus chromatographicus lateralis immunoassay pro detectione qualitativa multiplicium medicamentorum et metabolitarum medicamentorum in urinis ad concentrationes sequentes abscissorum:
| Test | Calibrator | Abscise (ng/mL) |
| Amphetamine (AMP1000) | D-Amphetamine | 1,000 |
| Amphetamine (AMP500) | D-Amphetamine | 500 |
| Amphetamine (AMP300) | D-Amphetamine | 300 |
| Benzodiazepines (BZO300) | Oxazepam | 300 |
| Benzodiazepines (BZO200) | Oxazepam | 200 |
| Barbiturates (BAR) | Secobarbital | 300 |
| Buprenorphine (BUP) | Buprenorphine | 10 |
| Cocaine (COC) | Benzoylecgonine | 300 |
| Cotinine (COT) | Cotinine | 200 |
| Methadone metabolite (EDDP) | 2-Ethylidine-1,5-dimethyl-3,3-diphenylpyrrolidine | 100 |
| Fentanyl (FYL) | Fentanyl | 200 |
| Ketamine (KET) | Ketamine | 1,000 |
| Synthetica Cannabinoidea (K2 50) | JWH-018 acidum 5-pentanoicum/JWH-073 4-acidi butanoicum | 50 |
| Synthetica Cannabinoidea (K2 200) | JWH-018 acidum 5-pentanoicum/JWH-073 4-acidi butanoicum | 200 |
| Methamphetamine (mAMP1000/ MET1000) | D-Methamphetamine | 1,000 |
| Methamphetamine (mAMP500/ MET500) | D-Methamphetamine | 500 |
| Methamphetamine (mAMP300/ MET300) | D-Methamphetamine | 300 |
| Methylenedioxymethamphetamine (MDMA) | D,L-Methylenedioxymethamphetamine | 500 |
| Morphine (MOP300/OPI300) | Morphine | 300 |
| Methadone (MTD) | Methadone | 300 |
| Methaqualone (MQL) | Methaqualone | 300 |
| Opiates (OPI 2000) | Morphine | 2,000 |
| Oxycodone (OXY) | Oxycodone | 100 |
| Phencyclidine (PCP) | Phencyclidine | 25 |
| Propoxyphene (PPX) | Propoxyphene | 300 |
| Antidepressants tricyclic (TCA) | Nortriptyline | 1,000 |
| Marijuana (THC) | 11-nec-9-THC-9-COOH | 50 |
| Tramadol (TRA) | Tramadol | 200 |
Configurationes Auctoritatis Celeri Test Kit AMRDT113 constare potest ex aliqua compositione analytarum medicamentorum supra enumeratorum.
Specimen urinae medicamento-positivae non generabit lineam coloratam in regione lineae probatae specificae habena propter medicamentorum competitions, dum specimen urinae negativae pharmacum generabit lineam in regione recta probata propter absentiam pharmaci competition.
Ut pro potestate processualis servetur, linea colorata semper in regione ditionis lineae apparebit, indicans volumen proprium speciminis additum esse et membranam wicking incidisse.
